Zachary H. Hopkins
· Assistant Professor (Clinical)VerifiedUniversity of Utah · Dermatology
Active 2015–2026
About
Dr. Zachary H. Hopkins is a board-certified dermatologist and a member of the American Academy of Dermatology, Society for Investigative Dermatology, and American DermatoEpidemiology Network. He completed his medical school training at the University of Utah School of Medicine and pursued a dermatology residency at Broward Health in Fort Lauderdale, Florida, where he developed a passion for complex medical dermatology and autoimmune dermatologic disease. He is actively pursuing advanced training in autoimmune dermatology with the University of Utah Autoimmune Dermatology group. His clinical interests include general dermatology, complex medical dermatology, blistering diseases, dermatomyositis, cutaneous lupus, vasculitis, and complex ulcers. Dr. Hopkins is an active clinical researcher studying the management of autoimmune diseases, including blistering and connective tissue diseases. He is also interested in epidemiology, research design, and promoting high-quality research methodology. Additionally, he is working to validate, develop, and implement patient-reported outcome measures to clinical visits. He has authored multiple high-impact journal articles and has spoken at national and international dermatology conferences.
Research topics
- Medicine
- Dermatology
- Computer Science
- Pathology
- Nursing
- World Wide Web
- Psychology
- Medical emergency
- Surgery
- Family medicine
- Emergency medicine
Selected publications
The role of antibody class and target on subepidermal blistering disease phenotype and management
Italian Journal of Dermatology and Venereology · 2026-03-01
articleOpen accessSenior authorCorrespondingSubepidermal blistering diseases are driven by autoantibodies targeted to the basement membrane zone. These autoantibodies can stem from multiple antibody classes (e.g., IgE, IgG, IgM, IgA) and differing antibody classes and antibody targets can impact disease phenotype and potentially management. Despite significant advances, there remains a paucity of data and funding for further elucidating subepidermal blistering disease pathophysiology and the impact this has on management. This review highlights current understanding of subepidermal blistering disease antibody targets, classes, and the impact these have on disease clinical phenotype and management. Highlighted conditions will include bullous pemphigoid, mucous membrane pemphigoid, including ocular cicatricial pemphigoid, linear IgA disease, and epidermolysis bullosa acquisita.
Archives of Dermatological Research · 2025-01-09
articleSenior author0371 Summarizing current core assessment domain establishment efforts
Journal of Investigative Dermatology · 2025-07-21
articleOpen accessSenior authorClinical assessment implications from core outcome domain set development exercises in dermatology
Journal of the American Academy of Dermatology · 2025-11-24
articleOpen accessSenior authorJournal of the American Academy of Dermatology · 2025-09-01
articleSenior author0288 Direct immunofluorescence for oral lichen planus
Journal of Investigative Dermatology · 2025-07-21
articleOpen accessSenior authorAn Allergy-Based Approach to Orofacial Granulomatosis: A Narrative Review
Dermatitis · 2025-09-19
articleSenior authorThe relationship between orofacial granulomatous (OFG) conditions and allergy is evolving. Contact allergies are commonly reported, but the impact of allergy avoidance is unclear, and a current review evaluating this literature has not been performed. We identified 46 studies evaluating the impact of allergen avoidance in OFG (33 case reports, 5 case series, 5 single-arm interventional clinical trials, 1 non-randomized uncontrolled trial, and 2 prospective cohort studies). Patch testing was performed in 158 patients, and the most commonly reported allergens were gold (n = 2), mercury (n = 6), cinnamal/cinnamon (n = 27), sorbic acid (n = 7), grass/silver birch/plant-containing products (n = 22), fragrance (n = 5), nickel (n = 7), and benzoic acid (n = 21). When allergen avoidance was trialed, 123/171 (71%) of patients reported some degree of improvement. A validated scoring/grading system for Granulomatous Cheilitis, Melkerrson-Rosenthal syndrome, and OFG has not been developed, so we were unable to formally assess improvement, instead relying on physician- and patient-reported outcomes in addition to oral disease severity score reporting in several studies. Current literature supports both patch testing and a trial of allergen avoidance/elimination diet to improve OFG in those with a positive result. Few controlled studies have been performed to assess this relationship, and more are needed to evaluate the impact of allergen avoidance. If a patient with difficult-to-treat OFG has a positive patch test and exposure to allergens in their diet, we would recommend a trial of allergen avoidance/elimination diet to facilitate a multimodal approach to improving control of this difficult condition.
Journal of the American Academy of Dermatology · 2025-09-01
articleJournal of Investigative Dermatology · 2025-07-21
articleOpen accessDermatologic Surgery · 2025-04-23
article
Frequent coauthors
- 54 shared
Aaron M. Secrest
University of Utah
- 15 shared
Christopher M. Moreno
University of Arizona
- 14 shared
Ryan Carlisle
University of Utah
- 10 shared
Dena Elkeeb
Mercy Health
- 9 shared
Vanina Taliercio
University of Utah
- 8 shared
Z. Frost
University of Utah
- 8 shared
David A. Wada
- 7 shared
Dustin Boothe
Intermountain Healthcare
Education
M.D.
University of Utah School of Medicine
Other, Dermatology
Broward Health
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Zachary H. Hopkins
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup